PetMed Express (NASDAQ:PETS) Cut to Hold at StockNews.com

PetMed Express (NASDAQ:PETS) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Tuesday.

PetMed Express Price Performance

NASDAQ PETS opened at $4.13 on Tuesday. The firm’s 50-day moving average is $5.11 and its two-hundred day moving average is $4.32. PetMed Express has a 12 month low of $2.90 and a 12 month high of $6.85. The stock has a market capitalization of $85.33 million, a P/E ratio of -68.83 and a beta of 0.70.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. As a group, analysts anticipate that PetMed Express will post 0.24 EPS for the current year.

Insider Buying and Selling

In other news, Director Leslie C.G. Campbell acquired 15,000 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The stock was acquired at an average cost of $5.38 per share, with a total value of $80,700.00. Following the completion of the acquisition, the director now owns 70,000 shares of the company’s stock, valued at $376,600. The trade was a 27.27 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On PetMed Express

Several hedge funds have recently modified their holdings of PETS. Arrowstreet Capital Limited Partnership raised its stake in shares of PetMed Express by 26.5% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 513,381 shares of the company’s stock worth $2,474,000 after buying an additional 107,614 shares during the last quarter. Geode Capital Management LLC raised its stake in PetMed Express by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 224,788 shares of the company’s stock valued at $1,084,000 after purchasing an additional 3,558 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of PetMed Express by 355.5% during the 4th quarter. JPMorgan Chase & Co. now owns 106,954 shares of the company’s stock valued at $516,000 after acquiring an additional 83,473 shares during the last quarter. Bleakley Financial Group LLC acquired a new position in shares of PetMed Express during the 3rd quarter valued at about $279,000. Finally, American Century Companies Inc. grew its holdings in shares of PetMed Express by 15.3% during the 4th quarter. American Century Companies Inc. now owns 33,662 shares of the company’s stock worth $162,000 after purchasing an additional 4,459 shares during the period. 73.33% of the stock is owned by institutional investors and hedge funds.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.